Lakeside Holding Ltd (LSH) Form S-3 — Jul 8, 2026
Lakeside Holding Limited filed a shelf registration statement on Form S-3 to offer and sell up to $120 million in aggregate principal amount of securities, which may include common stock, preferred stock, debt securities, warrants, rights, and units. The company intends to use any net proceeds for general corporate purposes as detailed in future prospectus supplements. The filing follows a strategic shift in February 2026, during which the company transferred its logistics operations to an unrelated third party to focus exclusively on pharmaceutical distribution in China through its subsidiary, Hupan Pharmaceutical.
Key figures
- Shares Outstanding
- 34427559
- Filing Fee
- $16,572
- Closing Stock Price
- $0.4198
- Common Stock Par Value
- $0.0001
- Aggregate Offering Amount
- $120,000,000
Price after filing
Close on the filing date to close N calendar days later (from $0.42). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.